SCHEMBL6540098

SCHEMBL6540098

COC(CCN)C(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21056291 1.00
SCHEMBL13591172 1.00
Hydrochloric Acid SCHEMBL21056277 1.00 GABRR1 (0.50)
SCHEMBL6787830 0.85 SLC1A3 (0.39)
SCHEMBL6789915 0.85 SLC1A3 (0.39)
SCHEMBL6539858 0.80
SCHEMBL6789204 0.80 HDAC2 (0.39)
Hydrochloric Acid SCHEMBL28754350 0.80
SCHEMBL21649465 0.79 GABRR1 (0.38)
SCHEMBL21649466 0.79 GABRR1 (0.38)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11608332-B2 FGFR4 inhibitor and preparation method and use thereof JIANGSU HANSOH PHARMACEUTICAL GROUP CO., LTD. (CN) 2023-03-21 US disclosed
CN-109563091-B FGFR4 inhibitor and preparation method and application thereof 江苏豪森药业集团有限公司 2022-04-29 CN disclosed
US-20220024913-A1 FGFR4 INHIBITOR AND PREPARATION METHOD AND USE THEREOF JIANGSU HANSOH PHARMACEUTICAL GROUP CO., LTD. (CN) 2022-01-27 US disclosed
EP-3498707-A1 FGFR4 INHIBITOR AND PREPARATION METHOD AND USE THEREOF Jiangsu Hansoh Pharmaceutical Group Co., Ltd. (CN) 2019-06-19 EP disclosed
US-6733985-B1 FOR MONITORING EXTRINSIC BLOOD COAGULATION ACTIVITIES; PREPARED FROM RECOMBINANT TISSUE FACTOR AND SYNTHETIC PHOSPHOLIPIDS INTERNATIONAL TECHNIDYNE CORPORATION 2004-05-11 US disclosed